- Home
- MPX vs ARCT Comparison
MPX vs ARCT Comparison
Compare MPX & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MPX | ARCT |
|---|---|---|
| Founded | 1965 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 264.3M | 245.4M |
| IPO Year | 2000 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MPX | ARCT |
|---|---|---|
| Price | $8.15 | $7.76 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $24.11 |
| AVG Volume (30 Days) | 57.9K | ★ 414.1K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 7.16% | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $244,419,000.00 | $82,031,000.00 |
| Revenue This Year | $13.72 | N/A |
| Revenue Next Year | N/A | $12.77 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.32 | N/A |
| 52 Week Low | $6.83 | $5.85 |
| 52 Week High | $10.08 | $24.14 |
Technical Indicators
Market Signals| Indicator | MPX | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 54.89 | 48.67 |
| Support Level | $7.89 | $6.34 |
| Resistance Level | $8.76 | $7.88 |
| Average True Range (ATR) | 0.25 | 0.59 |
| MACD | 0.01 | -0.09 |
| Stochastic Oscillator | 36.72 | 37.22 |
Price Performance
Historical ComparisonAbout MPX Marine Products Corporation
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. Its product offerings include Chaparral sterndrive, outboard pleasure boats, and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.